Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 231 $ 165
Accounts receivable, net 19,830 16,871
Inventories, net 6,402 4,821
Other current assets 4,157 2,922
Total current assets 30,620 24,779
Medical equipment for sale or rental 3,049 2,790
Medical equipment in rental service, net of accumulated depreciation 34,928 39,450
Property & equipment, net of accumulated depreciation 4,321 4,385
Goodwill 3,710 3,710
Intangible assets, net 7,446 8,436
Operating lease right of use assets 6,703 4,168
Deferred income taxes 9,115 9,625
Derivative financial instruments 1,442 1,965
Other assets 1,581 80
Total assets 102,915 99,388
Current liabilities:    
Accounts payable 8,009 8,341
Other current liabilities 7,704 6,126
Total current liabilities 15,713 14,467
Long-term debt, net of current portion 29,101 33,157
Operating lease liabilities, net of current portion 5,799 3,761
Total liabilities 50,613 51,385
Stockholders’ equity:    
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued 0 0
Common stock, $0.0001 par value: authorized 200,000,000 shares; 21,196,851 shares issued and outstanding as of December 31, 2023 and 20,781,977 shares issued and outstanding as of December 31, 2022 2 2
Additional paid-in capital 109,837 105,856
Accumulated other comprehensive income 1,088 1,489
Retained deficit (58,625) (59,344)
Total stockholders’ equity 52,302 48,003
Total liabilities and stockholders’ equity $ 102,915 $ 99,388